Seeking adults 18 years or older who have had 3 or more infections with Clostridium difficile (CDI) in the past 9 months including at the time they join the study. Half of the participants will be given the study drug and the other half will be given a placebo (fake pill). You cannot choose and will not be told which group you are in while in the study.
13 Studies found
Participants of the SERES-012 study may decide at Week 8 (if eligible) to join SERES-013, a follow on study in which all participants will receive the study drug.
We are collecting data and biological samples from people with infectious or inflammatory conditions of the bowel such as celiac disease, colitis, and Inflammatory Bowel Disease (IBD) and from people who do not have bowel disease to get a better understanding of these diseases.
Hepatitis C Therapeutic Registry And Research Network, A Longitudinal, Observational Study (Hcv-Target)
This is an observational study collecting information about patients diagnosed with chronic Hepatitis C viral (HCV) infection who are being treated with approved anti-HCV therapies. The purpose of this research study is to collect information about patients who are being treated for chronic hepatitis C virus (HCV).
Seeking healthy adults and adults who have been suffering influenza-like illness for no more than 14 days for a study of how the flu or flu-like infections affect their blood cells.
Seeking children who have been diagnosed with influenza in the past 7 days and healthy children willing to donate a blood sample for a study of how influenza affects blood cells of children.
An investigational drug (Favipiravir) study for patients who have been hospitalized with the coronavirus COVID-19.
Seeking men and women who have been hospitalized with the coronavirus COVID-19 for a study of an experimental drug.
This program provides access to investigational convalescent plasma for hospitalized patients infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease.
Seeking people, local to central Massachusetts, who are fully recovered from the new coronavirus to sign up to donate plasma to help current COVID-19 patients.
Seeking men and women who are in the hospital and diagnosed with COVID-19 for a study of an investigational drug to see if it acts as an anti-viral and anti-inflammatory treatment for COVID-19 infection.
Seeking people aged 12 and older who have been diagnosed with COVID-19 for an experimental treatment made from blood donated by people who have recovered from COVID-19.
Seeking hospitalized men and women who are receiving mechanical ventilation due to COVID-19 for a study to evaluate the efficacy and safety of an investigational drug.